ArticleBMC cancer2024

Immune-related adverse events correlate with the clinical efficacy in advanced Non-Small-Cell Lung Cancer patients treated with PD-1 inhibitors combination therapy.

Xiaowan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.